These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 8650156

  • 1. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
    Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5705-8. PubMed ID: 8650156
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.
    Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1998 Mar 17; 95(6):3003-7. PubMed ID: 9501205
    [Abstract] [Full Text] [Related]

  • 5. Bis-pyrrolyl-tetrazolyl derivatives as hybrid polar compounds: A case of lipophilic functional bioisosterism with bis-acetamides.
    Chatzopoulou M, Bonovolias ID, Nicolaou I, Demopoulos VJ, Vizirianakis IS, Tsiftsoglou AS.
    Eur J Med Chem; 2012 Apr 17; 50():75-80. PubMed ID: 22341896
    [Abstract] [Full Text] [Related]

  • 6. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.
    Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6746-50. PubMed ID: 8341693
    [Abstract] [Full Text] [Related]

  • 7. Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.
    Marks PA, Breslow R, Rifkind RA, Ngo L, Singh R.
    Proc Natl Acad Sci U S A; 1989 Aug 15; 86(16):6358-62. PubMed ID: 2762329
    [Abstract] [Full Text] [Related]

  • 8. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM, Rifkind RA, Marks PA.
    Cell Growth Differ; 1992 Jul 15; 3(7):413-20. PubMed ID: 1419904
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induced differentiation, the cell cycle, and the treatment of cancer.
    Rifkind RA, Richon VM, Marks PA.
    Pharmacol Ther; 1996 Jul 15; 69(2):97-102. PubMed ID: 8984510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells.
    Zhuo S, Fan S, Huang S, Kaufman S.
    Proc Natl Acad Sci U S A; 1995 May 09; 92(10):4234-8. PubMed ID: 7753788
    [Abstract] [Full Text] [Related]

  • 15. A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamide.
    Arcangeli A, Fontana L, Crociani O, Cherubini A, Hofmann G, Piccini E, Polvani S, D'Amico M, Carlà M, Olivotto M.
    Leukemia; 2000 Dec 09; 14(12):2112-7. PubMed ID: 11187900
    [Abstract] [Full Text] [Related]

  • 16. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 17. Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.
    Melloni E, Pontremoli S, Damiani G, Viotti P, Weich N, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1988 Jun 01; 85(11):3835-9. PubMed ID: 3163801
    [Abstract] [Full Text] [Related]

  • 18. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
    Yamashita T, Wakao H, Miyajima A, Asano S.
    Cancer Res; 1998 Feb 01; 58(3):556-61. PubMed ID: 9458105
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of Ran GTPase during HMBA-induced differentiation in murine erythroleukemia cells.
    Vanegas N, García-Sacristán A, López-Fernández LA, Párraga M, del Mazo J, Hernández P, Schvartzman JB, Krimer DB.
    Leuk Res; 2003 Jul 01; 27(7):607-15. PubMed ID: 12681360
    [Abstract] [Full Text] [Related]

  • 20. Changes in E2F DNA-binding activity during induced erythroid differentiation.
    Richon VM, Venta-Perez G.
    Cell Growth Differ; 1996 Jan 01; 7(1):31-42. PubMed ID: 8788031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.